According to the WHO's recently released worldwide cancer data for 2020, liver cancer
ranks sixth in morbidity and third in mortality among all malignancies. Hepatocellular …

The incidence of liver cancer is continuously rising where hepatocellular carcinoma (HCC)
remains the most common form of liver cancer accounting for approximately 80–90% of the …

Purpose Hepatocellular cancer is an insidious tumor that is often diagnosed in a later stage
of life. The tumor microenvironment is the key to tumorigenesis and progression. Many …

The prevalence of liver cancer is constantly rising, with increasing incidence and mortality in
Europe and the USA in recent decades. Among the different subtypes of liver cancers …

Immune associated cells in the microenvironment have a significant impact on the
development and progression of hepatocellular carcinoma (HCC) and have received more …

Hepatocellular carcinoma (HCC) remains a serious medical therapeutic challenge as
conventional curative avenues such as surgery and chemotherapy only benefit for few …

Hepatocellular carcinoma (HCC) is one of the most severe malignant tumors that threaten
human health, and its incidence is still on the rise recently. In spite of the current emerging …

Recent advancement in the immunological understanding of genesis of hepatocellular
carcinoma (HCC) has implicated a decline in anti-tumour immunity on the background of …

Incidence of hepatocellular carcinoma (HCC) is on the rise due to the prevalence of chronic
hepatitis and cirrhosis. Although there are surgical and chemotherapy treatment avenues …

Hepatocellular carcinoma (HCC) is the most common primary liver cancer and the fourth
leading cause of cancer-related death worldwide. HCC often occurs in the setting of chronic …